InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the complete record of transactions filed by Hodgson David C, Director. Director active across 5 companies, notably Alignment Healthcare, Inc.. Cumulatively, 18 reports have been published. History available since 27 August 2021. The latest transaction was disclosed on 13 March 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Hodgson David C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
18,982 shares0Common StockSEC:0001628280-26-018833:0
4,127 shares0Common StockSEC:0000937098-25-000104:0
7,614 shares0Class A Ordinary SharesSEC:0001802768-25-000053:0
18,710 shares0Common StockSEC:0001628280-25-013264:0
186 shares0Common StockSEC:0000937098-24-000174:0
9,293 shares0Class A Ordinary SharesSEC:0001802768-24-000033:0
2,930 shares0Common StockSEC:0000937098-24-000117:0
50,000 shares0Common StockSEC:0001209191-24-004869:0
7,747 shares0Class A Ordinary SharesSEC:0001209191-23-039686:0
79,891 shares0Common StockSEC:0000937098-23-000113:0
4,112 shares0Common StockSEC:0000937098-23-000084:0
36,337 shares0Common StockSEC:0001209191-23-017852:0
2,346 shares0Class A Ordinary SharesSEC:0001209191-22-041846:0
6,328 shares0Class A Ordinary SharesSEC:0000899243-22-024036:0
3,148 shares0Common StockSEC:0000937098-22-000097:0
16,556 shares0Common StockSEC:0001209191-22-017942:0
32,823 shares0Common Stock, par value $0.001 per share ("Common Stock")SEC:0000950142-21-002785:0
6,016 sharesCommon StockSEC:0000937098-16-000075:0
18 of 18 declarations
About Hodgson David C
HODGSON DAVID C is Administrateur at Alignment Healthcare, Inc., Trinet Group, INC., Royalty Pharma plc and TRINET GROUP INC. He has 18 filings, all in the available sample, with transactions of the nature “Attribution” over the period from 2016-02-12 to 2026-03-17; the reported buy and sell amounts are both EUR 0.
